Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
UBS
McKinsey
Federal Trade Commission
Chinese Patent Office
Merck
Medtronic
Daiichi Sankyo
Fish and Richardson
Farmers Insurance

Generated: October 22, 2017

DrugPatentWatch Database Preview

Qilu Pharm Co Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for QILU PHARM CO LTD, and what generic and branded alternatives to QILU PHARM CO LTD drugs are available?

QILU PHARM CO LTD has eight approved drugs.



Summary for Applicant: Qilu Pharm Co Ltd

US Patents:0
Tradenames:7
Ingredients:7
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qilu Pharm Co Ltd
OLANZAPINE
olanzapine
TABLET;ORAL204319-001Jan 27, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
CEFEPIME HYDROCHLORIDE
cefepime hydrochloride
INJECTABLE;INJECTION203704-002Feb 1, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)204368-003Jun 7, 2016APRXNoYes► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)204616-002May 11, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION203380-003May 3, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS203702-004Jun 29, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
INJECTABLE;INJECTION203711-001Sep 8, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION203380-001May 3, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
CEFEPIME HYDROCHLORIDE
cefepime hydrochloride
INJECTABLE;INJECTION203704-003Feb 1, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)204368-002Jun 7, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fuji
Argus Health
US Department of Justice
Chubb
Federal Trade Commission
McKesson
Johnson and Johnson
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot